Left Ventricular Assist Device Inflow Cannula Angle and Thrombosis Risk
نویسندگان
چکیده
منابع مشابه
Dynamic left ventricular assist device inflow obstruction.
A 72-year-old man with a history of rheumatic heart disease , prior bioprosthetic mitral and aortic valve replacement , severe nonischemic dilated cardiomyopathy (left ventricular [LV] ejection fraction 5%), and a history of ven-tricular tachycardia (VT) underwent implantation of a continuous flow LV assist device (LVAD; HeartMate II; Thoratec Corporation) as destination therapy for severe hear...
متن کاملTranscatheter aortic valve replacement performed via left ventricular assist device inflow cannula.
A 62-year-old woman with a history of lung cancer, prior surgical aortic valve replacement with a 23-mm Hancock (Medtronic, Inc, Minneapolis, MN) porcine valve, and non-ischemic cardiomyopathy supported with a HeartMate II destination therapy left ventricular assist device (LVAD; Thoratec Corporation, Pleasanton, CA) presented with hemolytic anemia (hemoglobin, 6.8 g/dL; lactate dehydrogenase, ...
متن کاملLeft ventricular-assist device arrest: total thrombosis of a continuous flow left ventricular-assist device.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . doi:10.1093/ehjci/jev290 Online publish-ahead-of-pr...
متن کاملUnexpected abrupt increase in left ventricular assist device thrombosis.
BACKGROUND We observed an apparent increase in the rate of device thrombosis among patients who received the HeartMate II left ventricular assist device, as compared with preapproval clinical-trial results and initial experience. We investigated the occurrence of pump thrombosis and elevated lactate dehydrogenase (LDH) levels, LDH levels presaging thrombosis (and associated hemolysis), and outc...
متن کاملPlatelet inhibition with ticagrelor for left ventricular assist device thrombosis.
A lthough considered standard therapy for Stage D heart failure since 2008, the continuous, axial flow HeartMate II (HMII) left ventricular assist device (LVAD) has recently been associated with unexpected rise in rates of pump thrombosis. 1 With an incidence of 0.01 to 0.11 events per patient-year, LVAD thrombosis responds to intensification of antithrombotic therapy with unfractionated hepari...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation: Heart Failure
سال: 2018
ISSN: 1941-3289,1941-3297
DOI: 10.1161/circheartfailure.117.004325